Posts in tag

ASX


Group reports total revenue of $4 billion, up 4.1% on the prior year, excluding PBS reforms and hepatitis C medicines API has reported earnings before interest and tax of $94 …

The “market-leading” healthcare group added just five retail pharmacies to its portfolio in Australia, after slowing down rollout of its pharmacy network Ramsay Health Care has announced a core net …

The digital medication management company has reported a 25% increase in operating revenue and 24% increase in gross profit following its expansion into the US and UK MedAdvisor has reported …

The discount pharmacy chain is reportedly set to float but investors may have to wait, with rumours the date has been pushed to late 2020 Pharmacy giant Chemist Warehouse has …

Full-year highlights included signed agreement with Chemist Warehouse Group for exclusive wholesale distribution, and moving to 100% ownership of TWC – but PBS reforms are having an impact EBOS Group …

Despite facing PBS reform and intense competition, API reports $25 million net profit after tax and $2 billion in revenue in its half-year results for 2019 Australian Pharmaceutical Industries (API) …

A review initiated after losing My Chemist/Chemist Warehouse supply contract has identified over $100m per year in savings Sigma Healthcare Limited has announced a “strong outlook” after conducting a review …

Under the scheme, API shareholders would own approximately 63% of the combined entity with Sigma shareholders owning the remaining 37% Australian Pharmaceutical Industries Limited (API) has today lodged a substantial …

PBS changes and exclusive direct distribution wiped more than $10 million in gross profit, according to FY18 results Australian Pharmaceutical Industries (API) has reported mixed results in its financial year …

MedAdvisor has reported a 31% increase in revenue on the same period last year, and expects to finalise a commercial agreement with TerryWhite Chemmart shortly Australian digital medication management company …

Half-year results show a 14.4% drop in reported net profit, which API says is primarily due to challenging retail conditions For the half year ending 28 February 2018, Australian Pharmaceutical …

Sales revenue was “heavily impacted” this year by a decline in the sales of low-margin hep C medicines Sigma Healthcare has reported a difficult financial year, but says it will …